POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE I

POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE I was reported 8 times

POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BETAXOLOL 2 0.0024
1 SITAGLIPTIN PHOSPHATE 1 0.0004
2 LIDOCAINE PATCH 5% 2 0.0003
3 HYOSCYAMINE SULFATE 2 0.0002
4 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 2 0.0002
5 PROGESTERONE 2 0.0001
6 LINACLOTIDE 2 0.0001
7 INSULIN GLARGINE-YFGN 1 0.0000
8 ERGOCALCIFEROL 1 0.0000
9 TEMAZEPAM 1 0.0000
10 IPILIMUMAB 1 0.0000
11 ADALIMUMAB-FKJP 1 0.0000
12 ADALIMUMAB-AATY 1 0.0000
13 ADALIMUMAB-ADAZ 1 0.0000
14 ENALAPRIL 1 0.0000
15 OCRELIZUMAB 1 0.0000
16 PANTOPRAZOLE SODIUM INJECTION 1 0.0000
17 EMPAGLIFLOZIN 1 0.0000
18 SECUKINUMAB 2 0.0000
19 DULAGLUTIDE 1 0.0000
20 NIVOLUMAB 1 0.0000
21 LEVOTHYROXINE SODIUM 3 0.0000
22 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
23 ALPRAZOLAM 2 0.0000
24 CYCLOSPORINE 1 0.0000
25 ACYCLOVIR 1 0.0000
26 MYCOPHENOLATE MOFETIL 1 0.0000
27 INSULIN LISPRO 1 0.0000
28 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
29 PANTOPRAZOLE SODIUM 1 0.0000
30 PREDNISOLONE ORAL SOLUTION 1 0.0000
31 RITUXIMAB 1 0.0000
32 INFLIXIMAB 1 0.0000
33 INSULIN GLARGINE 1 0.0000
34 PANTOPRAZOLE 1 0.0000
35 PREGABALIN 1 0.0000
36 PREDNISONE 1 0.0000
37 ASPIRIN 1 0.0000
38 ADALIMUMAB 1 0.0000